Texas
LATEST FROM BIOSPACE
Biopharma and life sciences companies made numerous appointments this week to boards and executive teams. These Movers & Shakers will position the companies for future growth.
As BioSpace proudly introduces our 2022 Hotbed Maps, let’s explore the industry’s most thriving territories, research leading employers and search for relevant jobs on BioSpace.
Heading into the middle of January, companies announced plenty of new clinical trial news. Here’s a look.
Vaccine development is experiencing a resurgence in the wake of the COVID-19 pandemic, with companies developing a variety of approaches.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
More than 103,000 people in the U.S. were hospitalized on January 3, 2022, for COVID-19—the highest daily figure of hospitalizations since last summer when the Delta variant emerged.
Low-income countries still struggle to get first jabs into arms. Researchers and pharma companies continue to push for low-cost vaccines and drugs worldwide.
The year kicked off with a bang as multiple companies raced to a public listing.
Now, researchers are on the threshold of great changes that have the potential to transform non-curable diseases into those that can be cured.
The 2021 San Antonio Breast Cancer Symposium is meeting December 7–10 at the Henry B. Gonzalez Convention Center in San Antonio, Texas, and virtually.
PRESS RELEASES